- CEO
- Jung-Soo Kim
- Full Time Employees
- 39
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Icheon-si South Korea
- Business
- SG HealthCare Co., Ltd. is a South Korea-based medical device manufacturer specializing in the development, production, and distribution of advanced diagnostic imaging equipment and artificial intelligence-driven medical software solutions. Founded in 2009 and headquartered in Icheon-si, Gyeonggi-do, South Korea, the company provides a comprehensive diagnostic imaging portfolio across human and veterinary healthcare sectors.
The company operates through diversified medical imaging product lines, offering digital radiography systems, including the Jumong series of ceiling-suspended, floor-mounted, mobile, and digital retrofit X-ray units as well as dual-purpose radiography and fluoroscopy systems; surgical C-arm fluoroscopy systems marketed under the Garion brand for real-time intraoperative visualization; multi-slice computed tomography scanners under the Dominus brand; magnetic resonance imaging systems under the Invictus brand, incorporating helium-free superconducting magnet technology; dental cone beam computed tomography devices marketed under the Hasla brand; portable and cart-based diagnostic ultrasound systems; proprietary artificial intelligence software platforms, including IAIA and ARIA, engineered for real-time medical image processing, noise reduction, radiation dose reduction, and computer-aided diagnostics; and specialized veterinary digital imaging equipment tailored for animal hospitals and clinics.
SG HealthCare delivers its imaging modalities and software solutions to general hospitals, specialized medical clinics, commercial diagnostic centers, dental practices, and veterinary institutions across more than 80 countries worldwide, including markets throughout Asia, Europe, the Middle East, Latin America, and Africa.
In recent corporate developments, SG HealthCare completed its public listing on the KOSDAQ market of the Korea Exchange under ticker symbol 398120 in December 2024 via a reverse merger with Hana Financial 22 Special Purpose Acquisition Company. In tandem with its public listing, the company has expanded its business strategy from standalone device manufacturing toward integrated healthcare service platforms, establishing international diagnostic center hubs, such as the Seoul Medical Center initiative in Central Asia, and accelerating the commercial rollout of proprietary AI deep-learning denoising algorithms across its diagnostic imaging product suite.